Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant LifeScience has informed that the Commissioner of State Excise, Maharashtra has passed an order dated March 3, 2018 cancelling DS-1 License and Form-I License relating to the Distillery operations of one of the factories located at Nira, Maharashtra and to take necessary criminal action. The Company is taking appropriate action against the Order since the manufacture and supply of alcohol is done only after obtaining necessary approvals of the state excise department. The Distillery operations of the Nira plant are in compliance with the conditions of DS-1 License and Form-I License. The cancellation of license for Distillery operations will have negligible impact on revenue and no impact on profitability of the Company and other Life Science Chemical products manufactured at this location will not get affected on account of this Order.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: